Health
US vaccine hopeful of using Gates Foundation cash to prepare for human trial – Hindustan Times
Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising…
Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their Covid-19 vaccine candidate toward 2021 human trials.
Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising for their single-dose candidate, targeted for room-temperature storage.
“We believe there is real potential,” Vandenberghe…
-
Noosa News19 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General18 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News17 hours agoMurray Watt claims Queensland will follow Sussan Ley and ditch net zero by 2050
-
General16 hours agoRussian barrage kills 25 in Ukraine city as Zelenskyy holds talks with Turkish leader